Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic advances in the targeting of ROR1 in hematological cancers.
Tigu AB, Munteanu R, Moldovan C, Rares D, Kegyes D, Tomai R, Moisoiu V, Ghiaur G, Tomuleasa C, Einsele H, Gulei D, Croce CM. Tigu AB, et al. Cell Death Discov. 2024 Nov 17;10(1):471. doi: 10.1038/s41420-024-02239-1. Cell Death Discov. 2024. PMID: 39551787 Free PMC article. Review.
5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity.
Munteanu RA, Moldovan CS, Tigu AB, Drula R, Feder R, Magdo L, Jurj A, Raduly L, Budisan L, Pirlog R, Moldovan A, Zimta AA, Braicu C, Preda A, Munteanu V, Romitan M, Gulei D, Ciuleanu TE. Munteanu RA, et al. Among authors: tigu ab. Med Pharm Rep. 2024 Oct;97(4):488-506. doi: 10.15386/mpr-2777. Epub 2024 Oct 30. Med Pharm Rep. 2024. PMID: 39502764 Free PMC article.
Single low-dose decitabine as frontline therapy of acute myeloid leukaemia, with venetoclax salvage.
Jitaru C, Peters MC, Aggarwal L, Bancos A, Tigu AB, Cenariu D, Selicean C, Pasca S, Moisoiu V, Rotariu P, Santa M, Iluta S, Drula R, Kegyes D, Kurtus A, Zdrenghea M, Gondek L, Tomuleasa C, Ghiaur G. Jitaru C, et al. Among authors: tigu ab. J Cell Mol Med. 2024 Oct;28(20):e18592. doi: 10.1111/jcmm.18592. J Cell Mol Med. 2024. PMID: 39435884 Free PMC article. No abstract available.
"Lazarus Response" When Feto-Maternal Microchimerism Kicks in: Spontaneous Remission in Refractory Primary Mediastinal B Cell Lymphoma Following Twin Pregnancy.
Tomai RA, Iluta S, Tigu AB, Nistor M, Bancos A, Cenariu D, Jitaru C, Patcas S, Dima D, Kegyes D, Buruiana S, Zdrenghea M, Tanase AD, Tomuleasa C, Micu R. Tomai RA, et al. Among authors: tigu ab. Diagnostics (Basel). 2024 Sep 20;14(18):2084. doi: 10.3390/diagnostics14182084. Diagnostics (Basel). 2024. PMID: 39335764 Free PMC article.
RNA methylation sequencing shows different gene expression signatures for response to azacytidine therapy in high-grade myelodysplastic syndromes.
Gulei D, Moisoiu V, Kegyes D, Drula R, Iluta S, Tigu AB, Nistor M, Jitaru C, Bancos A, Rotariu P, Popovici C, Dima D, Tomai R, Rus I, Constantinescu C, Munteanu R, Cenariu D, Sezerman U, Zdrenghea M, Cermak J, Einsele H, Ghiaur G, Tomuleasa C. Gulei D, et al. Among authors: tigu ab. J Cell Mol Med. 2024 Sep;28(18):e70078. doi: 10.1111/jcmm.70078. J Cell Mol Med. 2024. PMID: 39334509 Free PMC article.
Looking ahead to targeting macrophages by CAR T- or NK-cells in blood cancers.
Kegyes D, Milea PA, Mazga AI, Tigu AB, Nistor M, Cenariu D, Tomai R, Buruiana S, Einsele H, Daniela Tănase A, Tomuleasa C. Kegyes D, et al. Among authors: tigu ab. Expert Opin Ther Targets. 2024 Sep;28(9):779-787. doi: 10.1080/14728222.2024.2400075. Epub 2024 Sep 5. Expert Opin Ther Targets. 2024. PMID: 39235181 Review.
Therapeutic advances of targeting receptor tyrosine kinases in cancer.
Tomuleasa C, Tigu AB, Munteanu R, Moldovan CS, Kegyes D, Onaciu A, Gulei D, Ghiaur G, Einsele H, Croce CM. Tomuleasa C, et al. Among authors: tigu ab. Signal Transduct Target Ther. 2024 Aug 14;9(1):201. doi: 10.1038/s41392-024-01899-w. Signal Transduct Target Ther. 2024. PMID: 39138146 Free PMC article. Review.
57 results